[1]Xia,Ran;Sun,Li-Ping;Qu,Gui-Rong[Heterocycles,2015,vol.91,#12,p.2386-2393]
[1]CurrentPatentAssignee:XINXIANGUNIVERSITY-CN104892709,2018,BLocationinpatent:Paragraph0035;0036;0044;0045
Title: Nelarabine neurotoxicity with concurrent intrathecal chemotherapy: Case report and review of literature.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20150801
Title: Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120801
Title: Novel and emerging drugs for rarer chronic lymphoid leukaemias.
Journal: Current cancer drug targets 20120601
Title: Treatment of acute lymphoblastic leukemia in adults.
Journal: Critical reviews in oncology/hematology 20120101
Title: Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia.
Journal: Clinical Medicine Insights. Oncology 20120101
Title: Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias.
Journal: Current pharmaceutical design 20120101
Title: Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism.
Journal: PloS one 20120101
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation.
Journal: Blood 20110929
Title: Precursor T-Cell acute lymphoblastic leukemia/lymphoma with rare presentation in the urinary bladder.
Journal: Hematology reports 20110831
Title: In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia.
Journal: Blood 20110825
Title: [Novel conventional therapies in onco-hemathology].
Journal: Bulletin du cancer 20110801
Title: Phase I study of nelarabine in patients with relapsed or refractory T-ALL/T-LBL.
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20110601
Title: Educational paper. The development of new therapies for pediatric oncology.
Journal: European journal of pediatrics 20110501
Title: Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway.
Journal: European journal of nuclear medicine and molecular imaging 20110401
Title: New nucleoside analogs for patients with hematological malignancies.
Journal: Expert opinion on investigational drugs 20110301
Title: A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.
Journal: ISRN hematology 20110101
Title: Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemia.
Journal: Advances in hematology 20110101
Title: An update on the management of peripheral T-cell lymphoma and emerging treatment options.
Journal: Journal of blood medicine 20110101
Title: Rare tumors research in emerging countries.
Journal: Rare tumors 20100930
Title: Towards the development of a rapid, portable, surface enhanced Raman spectroscopy based cleaning verification system for the drug nelarabine.
Journal: The Journal of pharmacy and pharmacology 20100901
Title: Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma.
Journal: British journal of haematology 20100801
Title: Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.
Journal: American journal of hematology 20100801
Title: New trends in nucleoside biotechnology.
Journal: Acta naturae 20100701
Title: A new high-performance liquid chromatography method determines low production of 9-beta-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells.
Journal: Oncology reports 20100201
Title: Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
Journal: BMC health services research 20100101
Title: Use of clofarabine for acute childhood leukemia.
Journal: Biologics : targets & therapy 20100101
Title: Hydronephrosis Resulting from Bilateral Ureteral Stenosis: A Late Complication of Polyoma BK Virus Cystitis?
Journal: Journal of transplantation 20100101
Title: Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.
Journal: Molecular cancer 20100101
Title: Nelarabine in the treatment of refractory T-cell malignancies.
Journal: Clinical Medicine Insights. Oncology 20100101
Title: Application of new drugs in chronic lymphocytic leukemia.
Journal: Mediterranean journal of hematology and infectious diseases 20100101
Title: T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).
Journal: Blood 20091210
Title: Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
Journal: Hematology/oncology clinics of North America 20091001
Title: Nelarabine induced complete remission in an adult with refractory T-lineage acute lymphoblastic leukemia: A case report and review of the literature.
Journal: Leukemia research 20090701
Title: Novel therapies for relapsed acute lymphoblastic leukemia.
Journal: Current hematologic malignancy reports 20090701
Title: Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.
Journal: British journal of cancer 20090616
Title: Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.
Journal: Molecules (Basel, Switzerland) 20090323
Title: Nelarabine: new drug. T-lymphoblastic leukaemia/lymphoma: more evaluation needed.
Journal: Prescrire international 20090201
Title: [Severe liver injury following nelarabine chemotherapy for T-cell lymphoblastic lymphoma].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20090101
Title: Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia.
Journal: Drug design, development and therapy 20090101
Title: Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia.
Journal: OncoTargets and therapy 20090101
Title: Novel purine nucleoside analogues for hematological malignancies.
Journal: Recent patents on anti-cancer drug discovery 20080601
Title: FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Journal: The oncologist 20080601
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080501
Title: Beyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug development.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20080401
Title: Treating refractory leukemias in childhood, role of clofarabine.
Journal: Therapeutics and clinical risk management 20080401
Title: Phase I trial of nelarabine in indolent leukemias.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301
Title: Nelarabine.
Journal: Drugs 20080101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080101
Title: Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
Journal: Current medicinal chemistry 20080101
Title: Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.
Journal: Seminars in oncology 20071201
Title: Clinical management of T-cell malignancies: current perspectives, key issues, and emerging therapies.
Journal: Seminars in oncology 20071201
Title: Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Journal: Therapeutics and clinical risk management 20071201
Title: Nelarabine activity in acute biphenotypic leukemia.
Journal: Leukemia research 20071101
Title: Nelarabine: a novel purine antimetabolite antineoplastic agent.
Journal: Clinical therapeutics 20070901
Title: Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
Journal: Blood 20070615
Title: Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates.
Journal: Cancer chemotherapy and pharmacology 20070501
Title: In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia.
Journal: British journal of haematology 20070401
Title: New drugs 07, part I.
Journal: Nursing 20070201
Title: The long and winding road of the clinical development of Nelarabine.
Journal: Leukemia & lymphoma 20070101
Title: Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901.
Journal: Leukemia & lymphoma 20070101
Title: Treatment of acute lymphoblastic leukaemia : a new era.
Journal: Drugs 20070101
Title: Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma.
Journal: Expert opinion on investigational drugs 20061201
Title: Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia.
Journal: The Yale journal of biology and medicine 20061201
Title: Clofarabine and nelarabine: two new purine nucleoside analogs.
Journal: Current opinion in oncology 20061101
Title: Milestones in oncology: introducing a new section.
Journal: The oncologist 20061001
Title: The legacy of great science: the work of Nobel Laureate Gertrude Elion lives on.
Journal: The oncologist 20061001
Title: [Glaxo Smith Kline. A large oncology pipeline].
Journal: Medizinische Monatsschrift fur Pharmazeuten 20061001
Title: Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060915
Title: Nelarabine in the treatment of refractory T-cell malignant diseases.
Journal: Expert opinion on pharmacotherapy 20060901
Title: Nelarabine: a new purine analog in the treatment of hematologic malignancies.
Journal: Reviews on recent clinical trials 20060901
Title: Nelarabine: efficacy in the treatment of clinical malignancies.
Journal: Future oncology (London, England) 20060801
Title: Multifocal necrotizing leukoencephalopathy: An unusual complication of acute leukemia.
Journal: Archives of neurology 20060701
Title: Nelarabine use in leukemias.
Journal: Drugs of today (Barcelona, Spain : 1998) 20060701
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20060601
Title: Pharmacological and clinical studies on purine nucleoside analogs--new anticancer agents.
Journal: Mini reviews in medicinal chemistry 20060501
Title: Nelarabine (Arranon) for T-cell acute lymphoblastic leukemia.
Journal: The Medical letter on drugs and therapeutics 20060213
Title: Nelarabine.
Journal: Nature reviews. Drug discovery 20060101
Title: New drug to treat rare leukemia and lymphoma.
Journal: FDA consumer 20060101
Title: New drugs: abatacept, sorafenib, and nelarabine.
Journal: Journal of the American Pharmacists Association : JAPhA 20060101
Title: Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
Journal: Current medicinal chemistry 20060101
Title: Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.
Journal: Current cancer drug targets 20050901
Title: Nelarabine: a nucleoside analog with efficacy in T-cell and other leukemias.
Journal: The Annals of pharmacotherapy 20050601
Title: Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520
Title: Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520
Title: Purine nucleoside antimetabolites in development for the treatment of cancer.
Journal: Current opinion in investigational drugs (London, England : 2000) 20040601
Title: New nucleoside analogs in the treatment of hematological disorders.
Journal: Acta poloniae pharmaceutica 20040101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20031101
Title: Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
Journal: Cancer research 20020601
Title: CD4-CD8-'Double-negative' cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course.
Journal: The American journal of surgical pathology 20020201
Title: Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes.
Journal: Leukemia 20011201
Title: Nucleoside analogues in the treatment of haematological malignancies.
Journal: Expert opinion on pharmacotherapy 20010601
Title: Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010415
Title: 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.
Journal: Antimicrobial agents and chemotherapy 19910501
